These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. General considerations in the treatment of systemic lupus erythematosus. Rothfield NF Mayo Clin Proc; 1969 Sep; 44(9):691-6. PubMed ID: 5821139 [No Abstract] [Full Text] [Related]
31. Treatment of lupus erythematosus with antimalarials: results and incidents of treatment. BUREAU ; JARRY ; BARRIERE Bull Soc Fr Dermatol Syphiligr; 1954; 61(3):289-91. PubMed ID: 13199644 [No Abstract] [Full Text] [Related]
32. [Comparative data and remote results in therapy of lupus erythematosus with resochin, aminoquinol and other substances]. DMITRIEVA IN; BELUKHA UK Vestn Dermatol Venerol; 1962 Jan; 36():23-30. PubMed ID: 13886713 [No Abstract] [Full Text] [Related]
38. [Family Juvenile Systemic Lupus: about two families]. Krich S; Inani K; Meziane M; Souilmi FZ; Atmani S; Hida M; Harmouch T; Amarti A; Mernissi FZ Pan Afr Med J; 2015; 20():419. PubMed ID: 26301023 [TBL] [Abstract][Full Text] [Related]
39. [Lupus erythematosus and synthetic antimalarials: personal experience with nivaquine, its advantages over quinacrine, in 41 cases]. GRUPPER C Bull Mem Soc Med Hop Paris; 1953 Dec 11-18; 69(32-33):1077-9. PubMed ID: 13141156 [No Abstract] [Full Text] [Related]
40. [Lupus erythematosus and synthetic antimalarials; personal experience with nivaquine, and its advantages over quinacrine, based on 36 cases]. GRUPPER C Bull Soc Fr Dermatol Syphiligr; 1953; 60(5):423-8. PubMed ID: 13150041 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]